| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Short Communication |
1 MRC Virology Unit, Institute of Virology, University of Glasgow, Church Street, Glasgow G11 5JR, UK
2 The Institute of Infection, Immunity and Inflammation, School of Molecular Medical Sciences, The University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK
3 Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
Correspondence
Arvind H. Patel
a.patel{at}mrcvu.gla.ac.uk
The humoral response to hepatitis C virus (HCV) may contribute to controlling infection. We previously isolated human monoclonal antibodies to conformational epitopes on the HCV E2 glycoprotein. Here, we report on their ability to inhibit infection by retroviral pseudoparticles incorporating a panel of full-length E1E2 clones representing the full spectrum of genotypes 1–6. We identified one antibody, CBH-5, that was capable of neutralizing every genotype tested. It also potently inhibited chimeric cell culture-infectious HCV, which had genotype 2b envelope proteins in a genotype 2a (JFH-1) background. Analysis using a panel of alanine-substitution mutants of HCV E2 revealed that the epitope of CBH-5 includes amino acid residues that are required for binding of E2 to CD81, a cellular receptor essential for virus entry. This suggests that CBH-5 inhibits HCV infection by competing directly with CD81 for a binding site on E2.
These authors contributed equally to this work.
This article has been cited by other articles:
|
|
 |
|
  T. J. Broering, K. A. Garrity, N. K. Boatright, S. E. Sloan, F. Sandor, W. D. Thomas Jr., G. Szabo, R. W. Finberg, D. M. Ambrosino, and G. J. Babcock Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus J. Virol., December 1, 2009; 83(23): 12473 - 12482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Haid, T. Pietschmann, and E.-I. Pecheur Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles J. Biol. Chem., June 26, 2009; 284(26): 17657 - 17667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-y. Keck, S. H. Li, J. Xia, T. von Hahn, P. Balfe, J. A. McKeating, J. Witteveldt, A. H. Patel, H. Alter, C. M. Rice, et al. Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity J. Virol., June 15, 2009; 83(12): 6149 - 6160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Thomson Hepatitis C virus: the growing challenge Br. Med. Bull., March 1, 2009; 89(1): 153 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Witteveldt, M. J. Evans, J. Bitzegeio, G. Koutsoudakis, A. M. Owsianka, A. G. N. Angus, Z.-Y. Keck, S. K. H. Foung, T. Pietschmann, C. M. Rice, et al. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells J. Gen. Virol., January 1, 2009; 90(1): 48 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Grove, S. Nielsen, J. Zhong, M. F. Bassendine, H. E. Drummer, P. Balfe, and J. A. McKeating Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies J. Virol., December 15, 2008; 82(24): 12020 - 12029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gal-Tanamy, Z.-Y. Keck, M. Yi, J. A. McKeating, A. H. Patel, S. K. H. Foung, and S. M. Lemon In vitro selection of a neutralization-resistant hepatitis C virus escape mutant PNAS, December 9, 2008; 105(49): 19450 - 19455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fenouillet, D. Lavillette, S. Loureiro, G. Krashias, G. Maurin, F.-L. Cosset, I. M. Jones, and R. Barbouche Contribution of Redox Status to Hepatitis C Virus E2 Envelope Protein Function and Antigenicity J. Biol. Chem., September 26, 2008; 283(39): 26340 - 26348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Y. Keck, O. Olson, M. Gal-Tanamy, J. Xia, A. H. Patel, M. Dreux, F.-L. Cosset, S. M. Lemon, and S. K. H. Foung A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope J. Virol., June 15, 2008; 82(12): 6067 - 6072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-Y. Keck, T.-K. Li, J. Xia, M. Gal-Tanamy, O. Olson, S. H. Li, A. H. Patel, J. K. Ball, S. M. Lemon, and S. K. H. Foung Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies J. Virol., June 15, 2008; 82(12): 6061 - 6066. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
